| Ytd | 8.15% | |
| 1y | 65.82% |
| Open | 8.75 | Prev Close | 8.78 | Low | 8.39 | High | 8.76 | Mkt Cap | 1.52B |
| Vol | 928.23K | Avg Vol | 1.87M | EPS | 0.06 | P/E | 138.27 | Forward P/E | 109.89 |
| Beta | 0.62 | Short Ratio | 6.20 | Inst. Own | 62.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 7.13 | 200-d Avg | 7.08 | 1yr Est | 11.29 |
XERS News
Xeris Biopharma (XERS) was a big mover last session on higher-than-average trading volume. The lates
Please replace the release issued earlier today with the following corrected version that provides a
CHICAGO--(BUSINESS WIRE)-- #GvokeHypoPen--Please replace the release issued earlier today with the f
CHICAGO--(BUSINESS WIRE)-- #GvokeHypoPen--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-grow
CHICAGO--(BUSINESS WIRE)--Xeris Announces Updates to Its Board of Directors.
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdin
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu
Xeris Biopharma has delivered another year of significant revenue growth, signaling a pivotal moment
Xeris Biopharma NASDAQ: XERS reported a sharp increase in first-quarter 2026 revenue and raised the
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript
The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the q
CHICAGO--(BUSINESS WIRE)--XERIS BIOPHARMA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS.
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS - Get Free Report) has earned an average rating of "Mod
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS - Get Free Report) insider Beth Hecht sold 16,667 share
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceu
Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call Transcript
The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the q
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Tuesday